Equity in Bariatric Surgery Use: A Cohort Study

Victoria Gershuni,Elizabeth Wall-Wieler,Yuki Liu,Feibi Zheng,Maria S. Altieri

DOI: https://doi.org/10.1016/j.soard.2023.12.017

IF: 3.709

2024-01-10

Surgery for Obesity and Related Diseases

Abstract:Background Metabolic and bariatric surgery (MBS) is the most effective and durable treatment for obesity, however, access to MBS is not equitable. Objective To determine the rate of MBS among eligible adults with obesity by demographics, health characteristics, and geography to better define populations that would benefit from resources to reduce barriers to access for this treatment. Setting Adults with obesity were identified in US employer-based retrospective claims database (MerativeTM). Methods Rates of MBS were examined across demographics (age, sex, region, year, health plan type) health characteristics (obesity-related comorbidities, healthcare costs, inpatient admissions), and by state. Given differences in coverage requirements, rates are examined for two populations: Class 2 (BMI 35-39.9 kg/m 2 ) and Class 3 (BMI 40+ kg/m 2 ) obesity. Results Of the 777,565 eligible adults, 49,371 (6.4%) had MBS; 3.2% of those with Class 2 and 8.3% of those with Class 3 obesity had MBS. MBS rates varied substantially by demographic and health characteristics, ranging from 1% to 14%, and from 2% to 41% among those with Class 2 and Class 3 obesity, respectively. Geographically, rates ranged from 0% (Hawaii) to 7.4% (New Mexico) for those with Class 2 Obesity and from 4.2% (Hawaii) to 15.3% (Mississippi) among those with Class 3 Obesity. Conclusions Use of MBS among eligible adults with obesity varies substantially across characteristics, indicating inequity in access to this treatment. To ensure greater access to the most effective treatment for obesity, policies should be implemented to reduce or eliminate barriers to care.

surgery